2257 — Sirnaomics Income Statement
0.000.00%
- HK$375.09m
- HK$217.60m
Annual income statement for Sirnaomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16.9 | 46.2 | 216 | 96.6 | 84 |
Operating Profit | -16.9 | -46.2 | -216 | -96.6 | -84 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -17.1 | -46.4 | -216 | -97.4 | -85 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.1 | -46.4 | -216 | -97.4 | -85 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -16.4 | -43.8 | -213 | -88.3 | -78.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.4 | -43.8 | -213 | -88.3 | -78.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.181 | -0.397 | -13.5 | -1.16 | -0.95 |